| Literature DB >> 33283529 |
Arun Kumar Yadav1, Renu Madan1, Debajyoti Chatterjee2, Shalin Dhiman1, Shikha Goyal1, Narendra Kumar1, Sushanta Kumar Sahoo3.
Abstract
Small cell glioblastoma (scGBM) is a rare histological variant of classical glioblastoma (GBM). Presence of necrosis and microvascular proliferation is not essential for the diagnosis. It is thought to have more aggressive behavior as compared with classical GBM; however, because of its rarity standard treatment guidelines are not available. Adjuvant treatment for these cancers consists of postoperative radiotherapy with concurrent and maintenance temozolomide similar to classical GBM. Here we present a case series of five small cell glioblastoma patients along with the clinical-pathological review.Entities:
Keywords: concurrent chemotherapy; glioblastoma multiforme; glioma; high grade; immunohistochemistry; pathology; prognosis; radiotherapy; small cell; temozolomide
Year: 2020 PMID: 33283529 DOI: 10.2217/cns-2020-0016
Source DB: PubMed Journal: CNS Oncol ISSN: 2045-0907